Author

Martin Guggenberger

Observed names: Guggenberger, M., Guggenberger, Martin, M Guggenberger, M. Guggenberger

Observed institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen

OpenAlex ID: A5000405155

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study

2018 · N. Nabieva, T. Fehm, et al. · European Journal of Cancer · 55

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

2017 · N. Nabieva, S. Kellner, et al. · Annals of Oncology · 43

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

2016 · Carolin C. Hack, Peter A. Fasching, et al. · Integrative Cancer Therapies · 29

Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study

2014 · P. Fasching, T. Fehm, et al. · Geburtshilfe und Frauenheilkunde · 13

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

2019 · Markus Wallwiener, Naiba Nabieva, et al. · BMC Cancer · 10

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

2016 · Paul Gaß, Peter A. Fasching, et al. · Breast Care · 7

[40-year-old patient without previous illness with acute shock symptoms and disseminated intravascular coagulation].

1996 · G König, M Guggenberger, et al. · PubMed · 6

2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care · 2

Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study

2016 · CC Hack, PA Fasching, et al. · Geburtshilfe und Frauenheilkunde · 1

2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care · 1

1. Wissenschaftspreis – EvAluate-TM-Studie: Interesse an integrativer Medizin bei postmenopausalen Patientinnen mit hormonrezeptorpositivem Mammakarzinom und adjuvanter Letrozoltherapie

2016 · C. C. Hack, P. A. Fasching, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie

2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care

2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care

Meetings and Conferences

2016 · Demetrios Moris, Michalis Kontos, et al. · Breast Care

Supplementary Material for: Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study

2016 · Gaß, P., Fasching, P.A., et al. · Figshare

Evaluation des Therapiemanagements und der Therapieadhärenz bei postmenopausalen Patientinnen mit hormonrezeptorpositivem Mammakarzinom, die mit Letrozol behandelt werden – die EvaluateTM-Studie

2015 · P. Fasching, T. Fehm, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie

Works count: 18

Citation count: 167

H-index: 6

I10-index: 5